Q1 2025 Earnings Call Transcript May 13, 2025 Exelixis, Inc. beats earnings expectations. Reported EPS is $0.55, expectations ...

Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not ...

Meeting Received NDA Submission Planned this Summer KANSAS CITY, Kan., May 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc.

Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...

A seismic shift is underway for inflammatory bowel disease therapies as a trio of newly approved interleukin-23 inhibitors are poised to challenge both the resident blockbuster and an avalanche of its ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...

Americans are notoriously unhappy with healthcare. As of last December, Americans’ perception of the quality of US healthcare ...

Some new glow in the dark technology called Cytalux is helping remove cancer cells. Cytalux is the first and only ...